Atlas Trials

The Effects of oXiris in Cardiogenic Shock Requiring VA-ECMO

Clinical trial NCT05642273 · COMPLETED

Trial details

NCT number
NCT05642273
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cardiogenic Shock
Start date
2022-11-25
Primary completion
2024-01-08
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.